Skip to content

Study on Cardiopulmonary Function Interventions in People at Risk of Chronic Obstructive Pulmonary Disease

Study on Cardiopulmonary Function Interventions in People at Risk of Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085483
Enrollment
Unknown
Registered
2024-06-07
Start date
2024-06-12
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease and cardiovascular disease

Interventions

Intervention group 1:8 weeks of 50% to 60% MIP inspiratory muscle training, aerobic training, and resistance training.
Intervention group 2:8 weeks of 50% to 60% MIP inspiratory muscle training
Control group:Daily medical consultation

Sponsors

West China School of Public Health and West China Fourth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) According to the American Thoracic Association (ATS)/Respiratory ERS standards, patients with FEV1/FVC<0.70 and diagnosed with mild or above chronic obstructive pulmonary disease (predicted forced expiratory volume in 1 second (FEV1) less than 80%); (2) Age over 40 years old; (3) Arterial wave conduction velocity: PWV = 1400mm/s; (4) Agree to participate in this experiment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Has undergone pulmonary resection or lobectomy within the past 6 months; (2) Having pneumothorax or rib fractures; (3) Severe movement disorders (not caused by chronic obstructive pulmonary disease), or other neurological, muscular, skeletal, or cardiovascular diseases that seriously affect the safety of the subject's training; (4) Severe heart disease (acute heart failure or myocardial infarction, unstable angina, uncontrolled arrhythmia, third degree atrioventricular block patients, unexplained chest pain and palpitations); (5) Pregnancy or breastfeeding; (6) Individuals with cognitive impairment or other inability to cooperate with training; (7) Individuals who have not signed informed consent forms. (8) Participate in other similar experiments. (9) Strict inclusion and exclusion criteria will be applied to exclude subjects with a pulmonary bulla diameter greater than 1cm.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;degree of arteriosclerosis;

Secondary

MeasureTime frame
life-style;blood pressure;blood fat;blood sugar;

Countries

China

Contacts

Public ContactShujuan Yang

West China School of Public Health and West China Fourth Hospital

rekiny@126.com+86 189 8084 2145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026